Elixher Uncategorized HD21 phase III trial: Fertility outcomes in cHL with BrECADD vs eBEACOPP

HD21 phase III trial: Fertility outcomes in cHL with BrECADD vs eBEACOPP

A secondary analysis of the HD21 trial compared fertility outcomes in patients with classic Hodgkin lymphoma (cHL) treated with brentuximab …

Related Post